Pharma Blisters Packaging Market Size, Share, and Industry Analysis By Material (Plastic {PET, PE, PVC, and Others}, Aluminium, and Paper & Paperboard), By Technology (Thermoforming and Cold Forming), By Product Type (Clamshell and Carded), By Application (Tablets & Capsules, Syringes, Medical Devices, and Others), and Regional Forecast, 2024-2032

Pharma blisters packaging is a robust packaging solution that offers overall product protection to pharmaceutical products from factors such as air, moisture, and humidity and prevents contamination. Pharma blister packaging also offers excellent protection of the medicines, enhances dosage compliances, and provides ease of customization according to the desired product design, further driving the market growth. Rising development and innovations in pharma blisters that can ease product tracking through smartphones and remind patients to consume their required medications on time are generating profitable opportunities for market growth.

• For instance, in April 2021, Bostik announced the launch of a smart blister packaging solution for pharmaceutical products. HERBERTS™ EPS 8760/KN75 is a high-performance and smart adhesive that is designed to enhance the process automation of cold-forming blister packaging for the pharmaceutical sector.

Continuous innovations in product portfolio by major manufacturers, rising usage of smart packaging for patient engagement & identification, and increasing mergers & acquisitions to fulfil consumer demands are the major factors boosting the market growth. The expansion of advanced manufacturing processes to manufacture sustainable and eco-friendly packaging products is another factor propelling the market growth. In addition, the growing geriatric population and rising incidence of chronic diseases are also boosting the demand for new and effective pharmaceutical products, further driving the market expansion.

The fluctuations in raw materials costs are the major factors hindering the growth of the global pharma blister packaging market. In addition, the rising environmental concerns and the stringent regulations imposed on plastic usage by several government bodies are also limiting the market growth. Furthermore, the unsuitability of the blister packs for heavy pharmaceutical products will also disrupt the industry expansion.

IMPACT OF COVID-19 ON THE PHARMA BLISTERS PACKAGING MARKET

The occurrence of the COVID-19 virus majorly impacted several end-use industries worldwide. However, the pharmaceutical packaging industry did not face any major impacts. The healthcare & pharmaceutical sectors experienced a major rise in sales with the virus spread. Several clinical trials were performed. The sales of OTC drugs were also on the rise. The continuous spread of the virus across the globe boosted the demand for medicines, vaccines, and drugs, which further propelled the pharma blister packaging market growth. The need for vials & ampoules and rising supply of tablets & capsules also impelled the market growth.

KEY INSIGHTS

The report covers the following key insights:

• Recent Advancements in the Pharma Blisters Packaging Market


• Key Industry Trends


• Regulatory Landscape for the Pharma Blisters Packaging Market


• Key Industry Developments (Mergers, Acquisitions, and Partnerships)


• Impact of COVID-19 on the Market

SEGMENTATION

ANALYSIS BY MATERIAL

Based on material, the market is segmented into plastic, aluminium, and paper & paperboard. The plastic segment dominates the global pharma blisters packaging market. Plastic material offers excellent preservation and protection of product integrity. The products are clearly visible and as the material is durable, it can protect the drugs from moisture & gasses, further driving the segmental growth.

ANALYSIS BY TECHNOLOGY

Based on technology, the market is segmented into thermoforming and cold forming. The thermoforming segment leads the global pharma blisters packaging market. The technology is used to manufacture pharma blisters offers safe transit, eliminates risks of damage, and is cost-effective, owing to which the segment’s growth is flourishing.

ANALYSIS BY PRODUCT TYPE

Based on product type, the market is segmented into clamshell and carded. Carded product types dominate the global pharma blisters packaging market. Carded product types are a cost-effective and significant method of packaging tablets, capsules, and other nutraceutical products. The products can be easily stored and carried, as they take less space when packed in carded pharma blisters.

ANALYSIS BY APPLICATION

Based on application, the market is segmented into tablets & capsules, syringes, medical devices, and others. The tablets & capsules segment dominates the market and is set to witness significant growth over the projected period. Pharma blister packaging is majorly used for tablets and capsules as the blisters are cost-effective, child-resistant, and maintain high product integrity. The growing health-related issues and consumption of tablets and capsules drive the segmental growth.

REGIONAL ANALYSIS

The pharma blisters packaging market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the dominating region of the global pharma blister packaging market. The region’s well-established healthcare infrastructures and the presence of major pharmaceutical companies contribute to the market growth. In addition, the presence of major market players in the North American region also contributes to the market growth. Europe is the second-dominating region and is analysed to experience significant growth over the forecast period. The growing rate of drug development and increasing focus on providing sustainable packaging solutions drives regional growth.

Asia Pacific is the fastest-growing region. The rapidly growing healthcare industries, augmenting lifestyle-related diseases, and growing demand for nutrition tablets and capsules among the young population aid regional growth. The increasing geriatric population, along with the growing diseases drives the market growth in Latin America. The Middle East & Africa region will experience moderate growth over the forecast period due to the growing demand for cost-effective pharma packaging products.

KEY PLAYERS COVERED

The report includes the profiles of key players such as ACG Pharmapack Pvt. Ltd., Amcor Plc, Bilcare Research Inc., Constantia Flexibles GmBH, Honeywell International Inc., Pharma Packaging Solutions, Klöckner Pentaplast, Rohrer Corporation, Westrock, and Sonoco Products Company.

KEY INDUSTRY DEVELOPMENTS

• In October 2022, a U.S.-based pharmaceutical company, TekniPlex Healthcare, announced the debut of the world’s first completely transparent, recyclable mid-barrier blister package at Pack Expo, which was held from October 23 to 26 in Chicago. The company also premiered a completely recyclable polyester mono-material blister and lidding combination that is majorly suitable for products that do not require additional barrier protection.


• In April 2022, a key global provider of sustainable packaging solutions, Huhtamaki, announced the launch of a first-to-market sustainable innovation, especially for the global pharmaceutical and healthcare sector. Huhtamaki's Push Tab® blister lid is mono-material PET and is free from aluminium.


• In October 2021, Astellas Pharma announced the development of pharmaceutical blister packs that are developed with sugarcane-derived polyethylene as 50% of its raw material. The company further stated that the major move by them represents “the world’s first use” of biomass plastic specifically for drug blister packs.